Update on Emergency Contraception

Archived Sessions:

Learning Objectives

• Describe emergency contraceptive (EC) products, including progestin-only EC pills (ECPs), regimens, and ease of access, to ensure more consistent usage by patients
• Outline and discuss ECPs’ mechanism of action with patients in order to dispel myths surrounding ECPs
• Respond to patients’ concerns about the safety and efficacy of ECPs, according to FDA guidelines
• Provide evidence-based EC information and appropriate counseling and care to patients to insure improved patient health care outcomes

Accreditation Information

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses: This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hours, including up to 0.5 pharmacology hour. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

Pharmacists: The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit. The assigned universal program number for Preventing Unplanned Pregnancy: The Continued Need for Clinical Education about Emergency Contraception is 463-0000-10-018-C04-P.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit^TM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through an educational grant from Duramed Research, Inc., a subsidiary of Barr Pharmaceuticals.  

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

• Linda Dominguez, RN-C, NP:  Ms. Dominguez is a consultant/speaker for Teva/Barr, Wyeth, Schering Plough.  
• Donald F. Downing, RPh: Dr. Downing has no affiliations to disclose.
• Eleanor B. Schwarz, MD, MS: Dr. Schwarz has no affiliations to disclose.
• James Trussell, BPhil, PhD:  Dr. Trussell has no affiliations to disclose.
• Elizabeth Westley, MPH:  Ms. Westley has no affiliations to disclose.

ARHP Staff/Consultant Disclosures

• Jerry Blaivas, MD, Ellen Cohen, Cert Ed, Dip Ed, Delysha D'Mellow, MPH, Beth Jordan, MD, and Wayne Shields have no affiliations to disclose.